L-arginine in norm and pathology

Endocrinologist
L-arginine in norm and pathology

Abstract. L-arginine is a conditionally essential amino acid, which is the cellular regulator of many vital functions of the body. He is involved in the regulation of the tone of the smooth muscle component of the blood vessels wall, bronchi, and intestines. L-arginine is a substrate for the nitric oxide synthase (NOS), which produces nitric oxide (NO). NO, produced in the vascular endothelium of endothelial NOS, is responsible for the relaxation of smooth muscles and is necessary to lower blood pressure. L-arginine has a high functional priority in the production of NO and, therefore, in the physiology of the cardiovascular and cerebrovascular systems. L-arginine can reduce obesity, lower blood pressure, suppress oxidative processes and normalize endothelial dysfunction, contributing to remission in type 2 diabetes. L-arginine is also used by cells of the immune system, can reduce the level of infection, especially in case of impaired immune function. L-arginine slows down aging, inhibits platelet aggregation, and regulates multiple metabolic pathways associated with the metabolism of fatty acids, glucose, amino acids and proteins. Therefore, one should take into account the great therapeutic potential of L-arginine and continue to study the possibilities of its use as a promising drug against the progression of vascular dysfunction associated with aging, diabetes and cardiovascular diseases.

Keywords: L-arginine, nitric oxide, diabetes, cardiovascular system, obesity, cerebrovascular system, immune system, platelet aggregation.

13 January, 2020

Authors:

Learn more

Neurologist

Neurological disorders in patients who had COVID-19: how to treat during a pandemic

The article provides an overview of the world literature data on lesions of the nervous system in patients who had COVID-19. The results of an open comparative study on the effectiveness of combined use of Xavron, Tivor-L and Xylat in patients with neurological disorders in the post-COVID period are also presented. The positive effect of...
Endocrinologist

Pathogenetic pancreoprotection in diabetic ketoacidosis

Diabetes is an important medical and social problem, as it develops in each of the 11 adult inhabitants of the planet. In the complicated course of diabetes mellitus, ketoacidosis develops, which is the most common manifestation of acute hyperglycemia in people with both types of diabetes mellitus. The purpose of this study is to systematize...
Gastroenterologist

Pilot study of anxiolytic drug Lodixem in patients with acute decompensed heart failure

Anxiety disorders often accompany the course of cardiovascular disease and become more pronounced as they progress. Anxiety is also a frequent companion of patients with heart failure (HF). In a recent meta-analysis of 38 studies by K. Easton et al. (2015) estimated that 32% of patients with HF experience an increased level of anxiety, and...